A randomized, controlled trial of indinavir, zidovudine, and lamivudine in adults with advanced human immunodeficiency virus type 1 infection and prior antiretroviral therapy
Published inThe Journal of infectious diseases, vol. 180, no. 3, p. 659-665
Publication date1999
Abstract
Keywords
- Acquired Immunodeficiency Syndrome/ drug therapy/immunology/mortality
- Adult
- Anti-HIV Agents/ therapeutic use
- CD4 Lymphocyte Count
- Double-Blind Method
- Drug Administration Schedule
- Drug Therapy, Combination
- Female
- HIV Infections/ drug therapy/immunology/mortality
- Hiv-1
- Humans
- Indinavir/ therapeutic use
- Lamivudine/ therapeutic use
- Male
- Survival Rate
- Zidovudine/ therapeutic use
Affiliation entities
Citation (ISO format)
HIRSCH, M. et al. A randomized, controlled trial of indinavir, zidovudine, and lamivudine in adults with advanced human immunodeficiency virus type 1 infection and prior antiretroviral therapy. In: The Journal of infectious diseases, 1999, vol. 180, n° 3, p. 659–665. doi: 10.1086/314948
Main files (1)
Article
Identifiers
- PID : unige:7316
- DOI : 10.1086/314948
- PMID : 10438352
Journal ISSN0022-1899
